Atrial Fibrillation (AF) is a common condition in the aging population and is a strong risk factor for coronary artery diseases. The management of such patients is challenging, particularly those on antithrombotic therapy and requiring antiplatelet therapy after coronary intervention. Careful assessment of both thrombotic and bleeding risk and individualized decision-making is paramount to ensure the best patient outcomes.
Additionally, the management of hypertension is crucial. To gain expert insights in this regard, Docplexus has organized an interactive webinar in association with the Care Institute of Medical Sciences and Joint International Conference , on 31 st July 2020, 7 pm onwards. In this webinar, experts will discuss the role of antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention and guidelines for the management of…
